Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - New York Stock Exchange, Inc. - US60784B1017 - REIT - Currency: USD

14.1  -0.16 (-1.12%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MDV. MDV was compared to 129 industry peers in the Diversified REITs industry. MDV has only an average score on both its financial health and profitability. MDV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

MDV had negative earnings in the past year.
In the past year MDV had a positive cash flow from operations.
MDV had negative earnings in 4 of the past 5 years.
MDV had a positive operating cash flow in each of the past 5 years.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

MDV has a Return On Assets of -0.12%. This is in the lower half of the industry: MDV underperforms 60.47% of its industry peers.
The Return On Equity of MDV (-0.35%) is worse than 60.47% of its industry peers.
The Return On Invested Capital of MDV (3.12%) is better than 60.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDV is in line with the industry average of 3.15%.
The last Return On Invested Capital (3.12%) for MDV is above the 3 year average (2.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROIC 3.12%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

MDV has a better Operating Margin (42.50%) than 87.60% of its industry peers.
MDV's Operating Margin has improved in the last couple of years.
MDV's Gross Margin of 92.54% is amongst the best of the industry. MDV outperforms 93.80% of its industry peers.
In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.54%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

MDV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MDV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MDV has been increased compared to 5 years ago.
MDV has a worse debt/assets ratio than last year.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

MDV has an Altman-Z score of 0.10. This is a bad value and indicates that MDV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.10, MDV is not doing good in the industry: 72.87% of the companies in the same industry are doing better.
MDV has a debt to FCF ratio of 25.54. This is a negative value and a sign of low solvency as MDV would need 25.54 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 25.54, MDV is doing good in the industry, outperforming 74.42% of the companies in the same industry.
MDV has a Debt/Equity ratio of 1.63. This is a high value indicating a heavy dependency on external financing.
MDV has a worse Debt to Equity ratio (1.63) than 65.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Altman-Z 0.1
ROIC/WACC0.47
WACC6.64%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

MDV has a Current Ratio of 4.88. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
MDV has a Current ratio of 4.88. This is amongst the best in the industry. MDV outperforms 93.80% of its industry peers.
A Quick Ratio of 4.88 indicates that MDV has no problem at all paying its short term obligations.
MDV has a better Quick ratio (4.88) than 93.80% of its industry peers.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
MDV shows a decrease in Revenue. In the last year, the revenue decreased by -4.13%.
MDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.76% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%

3.2 Future

The Earnings Per Share is expected to grow by 2.94% on average over the next years.
Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-52.87%
EPS Next 2Y-16.32%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue Next Year3.08%
Revenue Next 2Y3.82%
Revenue Next 3Y2.24%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 80.54, which means the current valuation is very expensive for MDV.
The rest of the industry has a similar Price/Forward Earnings ratio as MDV.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, MDV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 80.54
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

72.87% of the companies in the same industry are more expensive than MDV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDV indicates a rather cheap valuation: MDV is cheaper than 87.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.03
EV/EBITDA 11.58
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.32%
EPS Next 3Y2.94%

More info and screens

4

5. Dividend

5.1 Amount

MDV has a Yearly Dividend Yield of 7.99%, which is a nice return.
MDV's Dividend Yield is a higher than the industry average which is at 6.68.
Compared to an average S&P500 Dividend Yield of 2.38, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.99%

5.2 History

MDV has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MDV are negative and hence is the payout ratio. MDV will probably not be able to sustain this dividend level.
DP-2417.04%
EPS Next 2Y-16.32%
EPS Next 3Y2.94%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

More info and screens

MODIV INDUSTRIAL INC

NYSE:MDV (6/3/2025, 10:41:54 AM)

14.1

-0.16 (-1.12%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)N/A N/A
Inst Owners15.42%
Inst Owner Change38.22%
Ins Owners3.19%
Ins Owner Change1.73%
Market Cap142.69M
Analysts84.44
Price Target18.36 (30.21%)
Short Float %0.23%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 7.99%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-2417.04%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.0975)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)143.79%
Min EPS beat(2)88.58%
Max EPS beat(2)199.01%
EPS beat(4)3
Avg EPS beat(4)-61.77%
Min EPS beat(4)-694.06%
Max EPS beat(4)199.01%
EPS beat(8)5
Avg EPS beat(8)48.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)400%
EPS NQ rev (3m)200%
EPS NY rev (1m)206.06%
EPS NY rev (3m)135.35%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 80.54
P/S 3.06
P/FCF 13.03
P/OCF 7.8
P/B 0.83
P/tB 0.84
EV/EBITDA 11.58
EPS(TTM)-0.09
EYN/A
EPS(NY)0.18
Fwd EY1.24%
FCF(TTM)1.08
FCFY7.68%
OCF(TTM)1.81
OCFY12.83%
SpS4.6
BVpS16.91
TBVpS16.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.16%
ROICexgc 3.19%
OM 42.5%
PM (TTM) N/A
GM 92.54%
FCFM 23.51%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexcg growth 3Y59.93%
ROICexcg growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Debt/EBITDA 7.75
Cap/Depr 45.14%
Cap/Sales 15.78%
Interest Coverage 1.5
Cash Conversion 50.72%
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z 0.1
F-Score5
WACC6.64%
ROIC/WACC0.47
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
EPS Next Y-52.87%
EPS Next 2Y-16.32%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%
Revenue Next Year3.08%
Revenue Next 2Y3.82%
Revenue Next 3Y2.24%
Revenue Next 5YN/A
EBIT growth 1Y117.17%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year80.32%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y114.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3Y23.3%
OCF growth 5Y30.88%